Wave Life Sciences (WVE) Revenue (2015 - 2026)

Wave Life Sciences' Revenue history runs 12 years deep, the most recent figure standing at $38.2 million for Q1 2026.

• Quarterly Revenue rose 316.85% year-over-year to $38.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $75.8 million (up 7.59% YoY) and the FY2025 annual result came in at $42.7 million, down 60.55% from the prior year.
• Revenue was $38.2 million for Q1 2026 at Wave Life Sciences, up from $8.7 million in the prior quarter.
• Across five years, Revenue topped out at $49.2 million in Q3 2023 and bottomed at $285000.0 in Q3 2022.
• A 5-year average of $15.8 million and a median of $12.5 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue sank 99.22% — and 2023, when it surged 17168.07%.
• Wave Life Sciences' Revenue stood at $1.2 million in 2022, then jumped by 2245.12% to $29.1 million in 2023, then slumped by 32.23% to $19.7 million in 2024, then sank by 55.82% to $8.7 million in 2025, then surged by 339.66% to $38.2 million in 2026.
• Business Quant data shows WVE's Revenue at $38.2 million in Q1 2026, $8.7 million in Q2 2025, and $9.2 million in Q1 2025.